TRODELVY FDA approval date

The FDA approved TRODELVY on 22 Apr 2020.

FDA approval date
22 Apr 2020

Drug identity has not yet been verified against registry records

Also recorded as SACITUZUMAB GOVITECAN-HZIY

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-04-22DayTRODELVYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761115", "applicant_as_listed_by_fda": "IMMUNOMEDICS INC", "brand_names": ["TRODELVY"], "active_ingredients": ["SACITUZUMAB GOVITECAN-HZIY"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200422", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026